Innovative cannabis delivery systems - Lift News
Friday, Apr 21, 2017

The ACMPR isn’t really innovative in the types of products it allows licensed producers to sell. The regulations only allow the sale of dried marijuana (which is currently carried by all licensed producers), fresh marijuana (which no LP has decided to sell as of yet), cannabis oil (which is being sold by over half of the LPs), and cannabis capsules (which are THC-capped by Health Canada, and only currently sold by Medreleaf). There’s been some fascinating maneuvering within these rules: Whistler Medical Marijuana recently announced the sale of a topical cannabis balm by characterizing it is a cannabis oil, thus allowing it to be sold to patients. Let’s take a look at some other innovative delivery systems being developed by LPs at the moment.

The Canna-wafer

CanniMed recently formed a partnership with Stoney Creek Ontario-based CTT Pharma. CTT is developing a wafer that enables medication, in this case cannabis, to be absorbed directly through the mucosa of the oral cavity, allowing for fast absorption and early onset of effects as it bypasses the liver. CanniMed believes this product will be especially helpful for those who have a fear of swallowing or choking. Think Listerine strips, but instead of fresh breath it delivers cannabinoid-based medicine.